Clinical Trial Update: Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study [Phase 2]

View source ↗

Summary

Phase 2 DECREASE study is evaluating lower-dose chemoradiation for early-stage anal cancer. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Basaloid Carcinoma
• Anal Canal Cloacogenic Carcinoma
• Anal Canal Squamous Cell Carcinoma
• Anal Cancer
• Anal Margin Squamous Cell Carcinoma

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING